Publications

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

 120
Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

Tags:

Previous Article

Interplay between mesothelial and immune cells in the tumor microenvironment

Next Article

LSD analogue with potential for treating schizophrenia

Related Posts

A ketogenic diet enhances aerobic exercise adaptation and promotes muscle mitochondrial remodeling in hyperglycemic male mice

A ketogenic diet enhances aerobic exercise adaptation a...

 60

Pharmacological administration of FGF21 reverses obesity through a parabrachial-projecting neuron population in the hindbrain

Pharmacological administration of FGF21 reverses obesit...

 35

Immune correlates and mechanisms of TIL therapy efficacy: current insights and knowledge gaps

Immune correlates and mechanisms of TIL therapy efficac...

 92